logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 68 Items
Showing 1 - 20 of 68 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Response to “treatment outcomes after offering same-day Initiation of human immunodeficiency virus (HIV) treatment—how to interpret discrepancies between different studies”

Schomaker M, Kerschberger B, Boulle AM
2023-08-05 • Clinical Infectious Diseases
2023-08-05 • Clinical Infectious Diseases
Journal Article
|
Research

Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model

Patten GE, Euvrard J, Anderegg N, Boulle AM, Arendse KD,  et al.
2022-11-24 • AIDS
2022-11-24 • AIDS
OBJECTIVE
Despite improved access to antiretroviral therapy (ART) for people with HIV (PWH), HIV continues to contribute considerably to morbidity and mortality. Increasingly, advanc...
Journal Article
|
Research

Attrition from care among men initiating ART in male-only clinics compared with men in general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Trivino Duran L,  et al.
2022-07-31 • AIDS and Behavior
2022-07-31 • AIDS and Behavior
Men have higher rates of attrition from antiretroviral therapy (ART) programs than women. In Khayelitsha, a high HIV prevalence area in South Africa, two public sector primary healthcare...
Journal Article
|
Letter

Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007-2012 in Khayelitsha, South Africa

Patten GE, Cox V, Stinson K, Boulle AM, Wilkinson LS
2014-04-23 • Clinical Infectious Diseases
2014-04-23 • Clinical Infectious Diseases
Journal Article
|
Review

Cohort profile: the Khayelitsha antiretroviral programme, Cape Town, South Africa

Stinson K, Goemaere E, Coetzee D, van Cutsem G, Hilderbrand K,  et al.
2016-05-20 • International Journal of Epidemiology
2016-05-20 • International Journal of Epidemiology
Journal Article
|
Research

HIV Viral Load as an Independent Risk Factor for Tuberculosis in South Africa: Collaborative Analysis of Cohort Studies

Fenner L, Atkinson A, Boulle AM, Fox MP, Prozesky HW,  et al.
2017-06-23 • Journal of the International AIDS Society
2017-06-23 • Journal of the International AIDS Society
Chronic immune activation due to ongoing HIV replication may lead to impaired immune responses against opportunistic infections such as tuberculosis (TB). We studied the role of HIV repl...
Journal Article
|
Research

Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study

Estill J, Egger M, Johnson LF, Gsponer T, Wandeler G,  et al.
2013-02-28 • PLOS One
2013-02-28 • PLOS One
OBJECTIVES
Mortality in patients starting antiretroviral therapy (ART) is higher in Malawi and Zambia than in South Africa. We examined whether different monitoring of ART (viral loa...
Journal Article
|
Research

Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey

Hwang B, Shroufi A, Gils T, Steele SJ, Grimsrud A,  et al.
2019-03-12 • PLOS One
2019-03-12 • PLOS One
BACKGROUND
HIV and TB programs have rapidly scaled-up over the past decade in Sub-Saharan Africa and uninterrupted supplies of those medicines are critical to their success. However,...
Protocol
|
Research Protocol

Elevation and cholera: an epidemiological spatial analysis of the cholera epidemic in Harare, Zimbabwe, 2008-2009

Fernandez MAL, Schomaker M, Mason PR, Fesselet JF, Baudot Y,  et al.
2012-06-18
2012-06-18
BACKGROUND
In highly populated African urban areas where access to clean water is a challenge, water source contamination is one of the most cited risk factors in a cholera epidemic....
Journal Article
|
Research

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Rice B, Boulle AM, Schwarcz S, Shroufi A, Rutherford G,  et al.
2019-03-20 • JMIR Public Health Surveill
2019-03-20 • JMIR Public Health Surveill
The move toward universal provision of antiretroviral therapy and the expansion of HIV viral load monitoring call into question the ongoing value of CD4 cell count testing and monitoring...
Journal Article
|
Research

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G,  et al.
2010-09-10 • AIDS
2010-09-10 • AIDS
OBJECTIVE: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, ...
Journal Article
|
Research

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration

Cornell M, Technau KG, Fairall L, Wood R, Moultrie H,  et al.
2009-09-01 • South African Medical Journal
2009-09-01 • South African Medical Journal
OBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South...
Journal Article
|
Research

Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa

Chu KM, Boulle AM, Ford NP, Goemaere E, Asselman V,  et al.
2010-02-17 • PLOS One
2010-02-17 • PLOS One
BACKGROUND: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen contain...
Journal Article
|
Research

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes

Ballif M, Zurcher K, Reid SE, Boulle AM, Fox MP,  et al.
2018-01-11 • BMJ Open
2018-01-11 • BMJ Open
Seasonal variations in tuberculosis diagnoses have been attributed to seasonal climatic changes and indoor crowding during colder winter months. We investigated trends in pulmonary tuber...
Journal Article
|
Research

Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa

Lawn SD, Campbell L, Kaplan R, Boulle AM, Cornell M,  et al.
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per micro...
Journal Article
|
Research

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

Rangaka MX, Wilkinson RJ, Boulle AM, Glynn JR, Fielding K,  et al.
2014-05-14 • Lancet
2014-05-14 • Lancet
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...
Journal Article
|
Research

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

Cox HS, Hughes J, Daniels J, Azevedo VD, McDermid C,  et al.
2014-04-01 • International Journal of Tuberculosis and Lung Disease
2014-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Khayelitsha, South Africa, a peri-urban township with high burdens of tuberculosis (TB), drug-resistant tuberculosis (DR-TB), and human immunodeficiency virus (HIV) infection.
Journal Article
|
Research

Attrition from HIV care among youth initiating ART in youth-only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C,  et al.
2022-01-25 • Journal of the International AIDS Society
2022-01-25 • Journal of the International AIDS Society
INTRODUCTION
Youth living with HIV (YLWH) are less likely to initiate antiretroviral therapy (ART) and remain in care than older adults. It is important to identify effective strate...
Journal Article
|
Research

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

Boulle AM, Schomaker M, May MT, Hogg RS, Shepherd B,  et al.
2014-09-09 • PLOS Medicine
2014-09-09 • PLOS Medicine
BACKGROUND
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-t...
Journal Article
|
Letter

Patients lost to care are more likely to be viremic than patients still in care

Stinson K, Ford NP, Cox V, Boulle AM
2014-02-05 • Clinical Infectious Diseases
2014-02-05 • Clinical Infectious Diseases